SPARC IBD Study
@SPARCIBD
Followers
44
Following
4
Media
0
Statuses
15
SPARC IBD—Study of a Prospective Adult Research Cohort with IBD—is a multicentered longitudinal study of adult IBD patients.
Joined May 2023
As part of #CCAwarenessWeek, we are making #IBDvisible by demystifying diet & nutrition. View educational resources about diet & nutrition, including Gut Friendly Recipes, which includes over 500 recipes vetted by dietitians who specialize in IBD, here: https://t.co/3zXN3OncKl
0
15
28
The Microbiome in Quiescent Crohn’s Disease with Persistent Symptoms S...
0
0
1
Are you ready to make #IBDVisible? See all of the ways you can get involved in #CCAwarenessWeek here: https://t.co/vXjFOETXMO
0
10
24
Extra-Intestinal Manifestations of Inflammatory Bowel Disease are Associated with Increased Biologic Cycling | Crohn's & Colitis 360 https://t.co/K86bMNhApv
academic.oup.com
AbstractBackground. Extraintestinal manifestations (EIMs) of inflammatory bowel disease (IBD) are a common, frequently debilitating complication of the dis
0
1
1
Dynamics of the Gut Mycobiome in Patients with Ulcerative Colitis - Clinical Gastroenterology and Hepatology ( https://t.co/fOMlX1XRRa)
0
1
0
study by my talented colleague @ryanungaro in @AGA_CGH ✅UST > VDZ after aTNF in 2 seperate cohorts (@MSHS_IBDCenter, @SPARCIBD) I’m excited cause…This study used data from @SPARCIBD @CrohnsColitisFn Check @SPARCIBD for your next research!! https://t.co/PGmG9HlmgZ
pubmed.ncbi.nlm.nih.gov
In 2 independent real-world cohort settings, second-line therapy in CD with ustekinumab after TNF antagonist treatment failure was associated with a lower likelihood of treatment failure than...
2
13
46
Please join us in welcoming our new Chief Scientific Officer, @moss_md! Learn more about Dr. Moss here: https://t.co/Sy1yHczAOo
2
2
49
Interpretable histopathology-based prediction of disease relevant features in Inflammatory Bowel Disease biopsies using weakly-supervised deep learning https://t.co/82akdYs6Rx
arxiv.org
Crohn's Disease (CD) and Ulcerative Colitis (UC) are the two main Inflammatory Bowel Disease (IBD) types. We developed deep learning models to identify histological disease features for both CD...
0
1
2
The Fecal Microbiome in Quiescent Crohn's Disease with Persistent Gastrointestinal Symptoms Show Enrichment of Oral Microbes But Depletion of Butyrate and Indole Producers https://t.co/74zfXiMPHU
pubmed.ncbi.nlm.nih.gov
Background: Persistent symptoms in quiescent Crohn's disease (CD) are prevalent and lead to worse outcomes. While changes in the microbial community have been implicated, the mechanisms by which...
0
1
2
Interpretable histopathology-based prediction of disease relevant features in Inflammatory Bowel Disease biopsies using weakly-supervised deep learning https://t.co/82akdYrz1Z
arxiv.org
Crohn's Disease (CD) and Ulcerative Colitis (UC) are the two main Inflammatory Bowel Disease (IBD) types. We developed deep learning models to identify histological disease features for both CD...
0
1
2
Second–Line Biologic Therapy Following Tumor Necrosis Factor Antagonist Failure: A Real–World Propensity Score–Weighted Analysis - Clinical Gastroenterology and Hepatology ( https://t.co/fOMlX1XRRa)
0
0
1
We asked our community what topic they want to learn about for our next MyIBD Learning webinar, and the results are in! Our next webinar will be Exploring Blood and Stool Tests in IBD. Register here to join us on June 14 at 8 p.m. ET: https://t.co/6iEJt127Sb
1
6
14
A new paper was published using SPARC data! https://t.co/UnKxs0shr1
0
1
2
Clinical Trials Day is May 20! Learn more about our Clinical Trials Community and how you can participate in research here: https://t.co/vI3PAGOtsS
0
6
19
